Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy
Abstract Traditional cancer therapies, such as surgery treatment, radiotherapy, and chemotherapy, often fail to completely eliminate tumor cells in an anaerobic microenvironment of tumor regions. In contrast to these traditional cancer therapies, the use of targeted delivery vectors to deliver antic...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-06-01
|
| Series: | Journal of Biological Engineering |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13036-019-0189-9 |
| _version_ | 1818281766789578752 |
|---|---|
| author | Lian He Huijun Yang Jianli Tang Zhudong Liu Yiyan Chen Binghua Lu Haocheng He Sijia Tang Yunjun Sun Fei Liu Xuezhi Ding Youming Zhang Shengbiao Hu Liqiu Xia |
| author_facet | Lian He Huijun Yang Jianli Tang Zhudong Liu Yiyan Chen Binghua Lu Haocheng He Sijia Tang Yunjun Sun Fei Liu Xuezhi Ding Youming Zhang Shengbiao Hu Liqiu Xia |
| author_sort | Lian He |
| collection | DOAJ |
| description | Abstract Traditional cancer therapies, such as surgery treatment, radiotherapy, and chemotherapy, often fail to completely eliminate tumor cells in an anaerobic microenvironment of tumor regions. In contrast to these traditional cancer therapies, the use of targeted delivery vectors to deliver anticancer genes or antitumor drugs to hypoxic areas in tumors is the most clinically promising cancer treatment with rapid development in recent years. In this study, E.coli Nissle 1917 (EcN), an intestinal probiotic, was utilized as a targeted transport vector to deliver p53 and Tum-5 protein to tumor hypoxic regions. The tumor-targeting characteristics of EcN were investigated using luciferase LuxCDABE operon, and the results demonstrated that EcN could specifically accumulate in the solid tumor areas of SMMC-7721 tumor-bearing BALB/c nude mice. The Tum 5-p53 bifunctional proteins were initially constructed and then delivered to solid tumor regions by using the targeted transporter EcN for cancer therapy. The antitumor effect and safety of three engineered bacteria, namely, EcN (Tum-5), EcN (p53), and EcN (Tum 5-p53), were also examined. The calculated tumor volume and tumor weight indicated that these three engineered bacteria could inhibit the growth of human hepatoma SMMC-7721 cells, and the antitumor effect of EcN (Tum 5-p53) expressing the Tum 5-p53 fusion protein was significantly better than those of EcN (Tum-5) and EcN (p53) alone. Immunofluorescence demonstrated that the expression of Ki-67, a nuclear proliferation-related protein, was inhibited in the tumor areas of the groups treated with the engineered bacteria, whereas the expression of caspase-3 was upregulated. The expression trends of Ki-67 and caspase-3 were consistent with the different antitumor efficacies of these three engineered bacteria. EcN did not elicit obvious side effects on mice. This research not only provids a foundation for tumor-targeted therapy but also contributes greatly to the development of antitumor agents and anticancer proteins. |
| first_indexed | 2024-12-13T00:10:20Z |
| format | Article |
| id | doaj.art-41aa37a2ef5d47c586768f6c8d9fbf94 |
| institution | Directory Open Access Journal |
| issn | 1754-1611 |
| language | English |
| last_indexed | 2024-12-13T00:10:20Z |
| publishDate | 2019-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Biological Engineering |
| spelling | doaj.art-41aa37a2ef5d47c586768f6c8d9fbf942022-12-22T00:05:59ZengBMCJournal of Biological Engineering1754-16112019-06-0113111310.1186/s13036-019-0189-9Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapyLian He0Huijun Yang1Jianli Tang2Zhudong Liu3Yiyan Chen4Binghua Lu5Haocheng He6Sijia Tang7Yunjun Sun8Fei Liu9Xuezhi Ding10Youming Zhang11Shengbiao Hu12Liqiu Xia13Hunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityHunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal UniversityAbstract Traditional cancer therapies, such as surgery treatment, radiotherapy, and chemotherapy, often fail to completely eliminate tumor cells in an anaerobic microenvironment of tumor regions. In contrast to these traditional cancer therapies, the use of targeted delivery vectors to deliver anticancer genes or antitumor drugs to hypoxic areas in tumors is the most clinically promising cancer treatment with rapid development in recent years. In this study, E.coli Nissle 1917 (EcN), an intestinal probiotic, was utilized as a targeted transport vector to deliver p53 and Tum-5 protein to tumor hypoxic regions. The tumor-targeting characteristics of EcN were investigated using luciferase LuxCDABE operon, and the results demonstrated that EcN could specifically accumulate in the solid tumor areas of SMMC-7721 tumor-bearing BALB/c nude mice. The Tum 5-p53 bifunctional proteins were initially constructed and then delivered to solid tumor regions by using the targeted transporter EcN for cancer therapy. The antitumor effect and safety of three engineered bacteria, namely, EcN (Tum-5), EcN (p53), and EcN (Tum 5-p53), were also examined. The calculated tumor volume and tumor weight indicated that these three engineered bacteria could inhibit the growth of human hepatoma SMMC-7721 cells, and the antitumor effect of EcN (Tum 5-p53) expressing the Tum 5-p53 fusion protein was significantly better than those of EcN (Tum-5) and EcN (p53) alone. Immunofluorescence demonstrated that the expression of Ki-67, a nuclear proliferation-related protein, was inhibited in the tumor areas of the groups treated with the engineered bacteria, whereas the expression of caspase-3 was upregulated. The expression trends of Ki-67 and caspase-3 were consistent with the different antitumor efficacies of these three engineered bacteria. EcN did not elicit obvious side effects on mice. This research not only provids a foundation for tumor-targeted therapy but also contributes greatly to the development of antitumor agents and anticancer proteins.http://link.springer.com/article/10.1186/s13036-019-0189-9E.coli Nissle 1917Targeted cancer therapyp53Tum-5Gene therapy |
| spellingShingle | Lian He Huijun Yang Jianli Tang Zhudong Liu Yiyan Chen Binghua Lu Haocheng He Sijia Tang Yunjun Sun Fei Liu Xuezhi Ding Youming Zhang Shengbiao Hu Liqiu Xia Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy Journal of Biological Engineering E.coli Nissle 1917 Targeted cancer therapy p53 Tum-5 Gene therapy |
| title | Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy |
| title_full | Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy |
| title_fullStr | Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy |
| title_full_unstemmed | Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy |
| title_short | Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy |
| title_sort | intestinal probiotics e coli nissle 1917 as a targeted vehicle for delivery of p53 and tum 5 to solid tumors for cancer therapy |
| topic | E.coli Nissle 1917 Targeted cancer therapy p53 Tum-5 Gene therapy |
| url | http://link.springer.com/article/10.1186/s13036-019-0189-9 |
| work_keys_str_mv | AT lianhe intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT huijunyang intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT jianlitang intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT zhudongliu intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT yiyanchen intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT binghualu intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT haochenghe intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT sijiatang intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT yunjunsun intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT feiliu intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT xuezhiding intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT youmingzhang intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT shengbiaohu intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy AT liqiuxia intestinalprobioticsecolinissle1917asatargetedvehiclefordeliveryofp53andtum5tosolidtumorsforcancertherapy |